Kendle kept at buy by Jefferies

Kendle International was reiterated by Jefferies & Co., Inc. analyst David Windley at buy with the price target raised to $36 from $32.50. Jefferies believes a strong late-stage environment support its three-year earnings-per-share growth forecast of 33%. Shares of the Cincinnati clinical research organization were down 14 cents, or 0.43%, at $32.50 on volume of 109,390 shares versus the three-month running average of 162,124 shares. (Nasdaq: KNDL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.